vs
Bionano Genomics, Inc.(BNGO)与沃特世(WAT)财务数据对比。点击上方公司名可切换其他公司
沃特世的季度营收约是Bionano Genomics, Inc.的117.3倍($932.4M vs $8.0M)。沃特世净利率更高(24.2% vs -99.8%,领先123.9%)。沃特世同比增速更快(6.8% vs -2.6%)。过去两年沃特世的营收复合增速更高(21.0% vs -4.8%)
Bionano Genomics是一家基因组技术企业,开发并销售专有光学基因组测绘技术及相关诊断解决方案,可高精度检测基因组大型结构变异,服务全球学术研究机构、生物制药企业与临床诊断实验室,产品应用于肿瘤、罕见病研究等领域。
沃特世是总部位于美国马萨诸塞州米尔福德的企业,面向生命科学、材料、食品等行业,提供色谱、质谱、实验室信息学、流变测量领域所用的分析仪器及配套软件,为各领域的检测、研发等工作提供可靠技术支持。
BNGO vs WAT — 直观对比
营收规模更大
WAT
是对方的117.3倍
$8.0M
营收增速更快
WAT
高出9.4%
-2.6%
净利率更高
WAT
高出123.9%
-99.8%
两年增速更快
WAT
近两年复合增速
-4.8%
损益表 — Q4 2025 vs Q4 2025
| 指标 | ||
|---|---|---|
| 营收 | $8.0M | $932.4M |
| 净利润 | $-7.9M | $225.2M |
| 毛利率 | 42.8% | 61.1% |
| 营业利润率 | -107.4% | 29.0% |
| 净利率 | -99.8% | 24.2% |
| 营收同比 | -2.6% | 6.8% |
| 净利润同比 | 60.6% | -2.7% |
| 每股收益(稀释后) | $-0.12 | $3.76 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比,按日历期对齐,财年错位的公司也能正确匹配
营收
BNGO
WAT
| Q4 25 | $8.0M | $932.4M | ||
| Q3 25 | $7.4M | $799.9M | ||
| Q2 25 | $6.7M | $771.3M | ||
| Q1 25 | $6.5M | $661.7M | ||
| Q4 24 | $8.2M | $872.7M | ||
| Q3 24 | $6.1M | $740.3M | ||
| Q2 24 | $7.8M | $708.5M | ||
| Q1 24 | $8.8M | $636.8M |
净利润
BNGO
WAT
| Q4 25 | $-7.9M | $225.2M | ||
| Q3 25 | $-8.5M | $148.9M | ||
| Q2 25 | $-6.9M | $147.1M | ||
| Q1 25 | $-3.1M | $121.4M | ||
| Q4 24 | $-20.1M | $231.4M | ||
| Q3 24 | $-44.2M | $161.5M | ||
| Q2 24 | $-16.2M | $142.7M | ||
| Q1 24 | $-31.4M | $102.2M |
毛利率
BNGO
WAT
| Q4 25 | 42.8% | 61.1% | ||
| Q3 25 | 45.7% | 59.0% | ||
| Q2 25 | 51.6% | 58.3% | ||
| Q1 25 | 45.5% | 58.2% | ||
| Q4 24 | 41.9% | 60.1% | ||
| Q3 24 | -139.1% | 59.3% | ||
| Q2 24 | 33.3% | 59.3% | ||
| Q1 24 | 32.2% | 58.9% |
营业利润率
BNGO
WAT
| Q4 25 | -107.4% | 29.0% | ||
| Q3 25 | -115.9% | 24.0% | ||
| Q2 25 | -115.8% | 24.4% | ||
| Q1 25 | -131.1% | 22.9% | ||
| Q4 24 | -146.3% | 33.5% | ||
| Q3 24 | -722.9% | 28.5% | ||
| Q2 24 | -219.0% | 26.7% | ||
| Q1 24 | -354.9% | 21.0% |
净利率
BNGO
WAT
| Q4 25 | -99.8% | 24.2% | ||
| Q3 25 | -115.4% | 18.6% | ||
| Q2 25 | -101.8% | 19.1% | ||
| Q1 25 | -48.0% | 18.3% | ||
| Q4 24 | -246.5% | 26.5% | ||
| Q3 24 | -728.6% | 21.8% | ||
| Q2 24 | -208.8% | 20.1% | ||
| Q1 24 | -358.3% | 16.0% |
每股收益(稀释后)
BNGO
WAT
| Q4 25 | $-0.12 | $3.76 | ||
| Q3 25 | $-1.59 | $2.50 | ||
| Q2 25 | $-1.99 | $2.47 | ||
| Q1 25 | $-1.15 | $2.03 | ||
| Q4 24 | $-7.05 | $3.88 | ||
| Q3 24 | $-30.92 | $2.71 | ||
| Q2 24 | $-14.41 | $2.40 | ||
| Q1 24 | $-35.75 | $1.72 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | ||
|---|---|---|
| 现金及短期投资手头流动性 | $3.0M | $587.8M |
| 总债务越低越好 | — | $1.4B |
| 股东权益账面价值 | $44.4M | $2.6B |
| 总资产 | $73.6M | $5.1B |
| 负债/权益比越低杠杆越低 | — | 0.55× |
8季度趋势,按日历期对齐
现金及短期投资
BNGO
WAT
| Q4 25 | $3.0M | $587.8M | ||
| Q3 25 | $3.1M | $459.1M | ||
| Q2 25 | $3.6M | $367.2M | ||
| Q1 25 | $3.6M | $382.9M | ||
| Q4 24 | $9.2M | $325.4M | ||
| Q3 24 | $8.8M | $331.5M | ||
| Q2 24 | $10.4M | $327.4M | ||
| Q1 24 | $15.8M | $338.2M |
总债务
BNGO
WAT
| Q4 25 | — | $1.4B | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | $1.6B | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
股东权益
BNGO
WAT
| Q4 25 | $44.4M | $2.6B | ||
| Q3 25 | $49.8M | $2.3B | ||
| Q2 25 | $45.4M | $2.2B | ||
| Q1 25 | $48.2M | $2.0B | ||
| Q4 24 | $35.4M | $1.8B | ||
| Q3 24 | $48.9M | $1.6B | ||
| Q2 24 | $80.3M | $1.4B | ||
| Q1 24 | $82.8M | $1.3B |
总资产
BNGO
WAT
| Q4 25 | $73.6M | $5.1B | ||
| Q3 25 | $79.1M | $4.9B | ||
| Q2 25 | $76.0M | $4.7B | ||
| Q1 25 | $78.4M | $4.6B | ||
| Q4 24 | $76.7M | $4.6B | ||
| Q3 24 | $87.4M | $4.5B | ||
| Q2 24 | $129.4M | $4.4B | ||
| Q1 24 | $158.0M | $4.5B |
负债/权益比
BNGO
WAT
| Q4 25 | — | 0.55× | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | 0.89× | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | ||
|---|---|---|
| 经营现金流最新季度 | $-4.2M | $164.6M |
| 自由现金流经营现金流 - 资本支出 | — | — |
| 自由现金流率自由现金流/营收 | — | — |
| 资本支出强度资本支出/营收 | — | — |
| 现金转化率经营现金流/净利润 | — | 0.73× |
| 过去12个月自由现金流最近4个季度 | — | — |
8季度趋势,按日历期对齐
经营现金流
BNGO
WAT
| Q4 25 | $-4.2M | $164.6M | ||
| Q3 25 | $-5.9M | $187.3M | ||
| Q2 25 | $-3.5M | $41.1M | ||
| Q1 25 | $-2.8M | $259.6M | ||
| Q4 24 | $-6.5M | $240.1M | ||
| Q3 24 | $-13.3M | $204.6M | ||
| Q2 24 | $-21.0M | $54.5M | ||
| Q1 24 | $-28.1M | $262.9M |
现金转化率
BNGO
WAT
| Q4 25 | — | 0.73× | ||
| Q3 25 | — | 1.26× | ||
| Q2 25 | — | 0.28× | ||
| Q1 25 | — | 2.14× | ||
| Q4 24 | — | 1.04× | ||
| Q3 24 | — | 1.27× | ||
| Q2 24 | — | 0.38× | ||
| Q1 24 | — | 2.57× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图